These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 30210600
1. Modified Huangqi Chifeng decoction inhibits excessive autophagy to protect against Doxorubicin-induced nephrotic syndrome in rats via the PI3K/mTOR signaling pathway. Yu ZK, Yang B, Zhang Y, Li LS, Zhao JN, Hao W. Exp Ther Med; 2018 Sep; 16(3):2490-2498. PubMed ID: 30210600 [Abstract] [Full Text] [Related]
2. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways. Zhao M, Yin Y, Yang B, Chang M, Ma S, Shi X, Li Q, Li P, Zhang Y. J Ethnopharmacol; 2024 Mar 01; 321():117520. PubMed ID: 38042389 [Abstract] [Full Text] [Related]
3. Protective effect of modified Huangqi Chifeng decoction on immunoglobulin A nephropathy through toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway. Liusheng LI, Mingming Z, Meiying C, Yuan SI, Jinning Z, Bin Y, Yu Z. J Tradit Chin Med; 2024 Apr 01; 44(2):324-333. PubMed ID: 38504538 [Abstract] [Full Text] [Related]
4. Modified Huangqi Chifeng Decoction Attenuates Proteinuria by Reducing Podocyte Injury in a Rat Model of Immunoglobulin a Nephropathy. Chang M, Yang B, Li L, Si Y, Zhao M, Hao W, Zhao J, Zhang Y. Front Pharmacol; 2021 Apr 01; 12():714584. PubMed ID: 34381367 [Abstract] [Full Text] [Related]
5. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway. Chen J, Yuan S, Zhou J, Huang X, Wu W, Cao Y, Liu H, Hu Q, Li X, Guan X, Yin S, Jiang J, Zhou Y, Zhou J. Phytomedicine; 2022 Dec 01; 107():154477. PubMed ID: 36215790 [Abstract] [Full Text] [Related]
6. Efficacy of Modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-β1/Smad3 signaling pathway through exosome regulation. Zhao M, Yang B, Li L, Si Y, Chang M, Ma S, Li R, Wang Y, Zhang Y. J Ethnopharmacol; 2022 Mar 01; 285():114795. PubMed ID: 34737009 [Abstract] [Full Text] [Related]
7. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes. Han J, Zhang Y, Shi X, Peng Z, Xing Y, Pang X. J Tradit Chin Med; 2021 Feb 01; 41(1):125-132. PubMed ID: 33522205 [Abstract] [Full Text] [Related]
11. Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy. Xuan C, Xi YM, Zhang YD, Tao CH, Zhang LY, Cao WF. Front Pharmacol; 2021 Feb 01; 12():624404. PubMed ID: 33912044 [Abstract] [Full Text] [Related]
12. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury. Wu JB, Ye SF, Liang CL, Li YC, Yu YJ, Lai JM, Lin H, Zheng J, Zhou JY. J Ethnopharmacol; 2014 Feb 12; 151(3):1124-1132. PubMed ID: 24389029 [Abstract] [Full Text] [Related]
16. Shensu IV prevents glomerular podocyte injury in nephrotic rats via promoting lncRNA H19/DIRAS3-mediated autophagy. Huang Y, Huang Y, Zhou Y, Cheng J, Wan C, Wang M, Pi C, Wu G, Song W. Biosci Rep; 2021 May 28; 41(5):. PubMed ID: 33881140 [Abstract] [Full Text] [Related]
17. Pingchuanning decoction attenuates airway inflammation by suppressing autophagy via phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in rat models of asthma. Wang X, Gao Y, Yang Q, Fang X, Li Z. J Cell Biochem; 2019 Mar 28; 120(3):3833-3844. PubMed ID: 30260006 [Abstract] [Full Text] [Related]
18. Mechanism underlying the inhibitory effect of Apelin-13 on glucose deprivation-induced autophagy in rat cardiomyocytes. Jiao H, Zhang Z, Ma Q, Fu W, Liu Z. Exp Ther Med; 2013 Mar 28; 5(3):797-802. PubMed ID: 23403698 [Abstract] [Full Text] [Related]
19. Choline Inhibits Ischemia-Reperfusion-Induced Cardiomyocyte Autophagy in Rat Myocardium by Activating Akt/mTOR Signaling. Hang P, Zhao J, Su Z, Sun H, Chen T, Zhao L, Du Z. Cell Physiol Biochem; 2018 Mar 28; 45(5):2136-2144. PubMed ID: 29533930 [Abstract] [Full Text] [Related]
20. Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway. Wei R, Liu H, Chen R, Sheng Y, Liu T. Exp Ther Med; 2019 Jan 28; 17(1):393-397. PubMed ID: 30651810 [Abstract] [Full Text] [Related] Page: [Next] [New Search]